Charles River Laboratories
556 hedge funds and large institutions have $7.92B invested in Charles River Laboratories in 2025 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 190 increasing their positions, 190 reducing their positions, and 56 closing their positions.
77% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 56
22% more call options, than puts
Call options by funds: $35.1M | Put options by funds: $28.7M
7% more funds holding
Funds holding: 519 → 556 (+37)
2% more capital invested
Capital invested by funds: $7.73B → $7.92B (+$189M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 190 | Existing positions reduced: 190
1.13% less ownership
Funds ownership: 103.62% → 102.49% (-1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$91.3M |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$81.3M |
| 3 |
D.E. Shaw & Co
New York
|
+$56M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$53.2M |
| 5 |
Harris Associates
Chicago,
Illinois
|
+$49.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$121M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$91.7M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$87.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$70.9M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$50.8M |
CRL Hedge Fund Activity: Q3 2025 in Review
556 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q3 2025, worth a combined $7.92B — up 2.4% from $7.73B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new CRL positions and 56 closed out — a net gain of 43 holders — while 190 added to existing stakes and 190 trimmed.
The largest buyer was Ameriprise, adding an estimated $91.3M. The largest seller was Nomura Holdings, cutting an estimated $121M.
- 556 institutional investors held Charles River Laboratories (CRL) as of Q3 2025, up from 519 in Q2 2025.
- Funds reported $7.92B of Charles River Laboratories stock for Q3 2025, up 2.4% quarter-over-quarter.
- 99 funds opened new Charles River Laboratories positions in Q3 2025 and 56 closed out, a net change of +43 holders.
- The largest Charles River Laboratories buyer in Q3 2025 was Ameriprise, an estimated $91.3M added.
- The largest Charles River Laboratories seller in Q3 2025 was Nomura Holdings, an estimated $121M sold.
Based on aggregated 13F filings for Q3 2025.